We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ruling in Generic Famvir Case Goes Against Teva’s Gamble
Ruling in Generic Famvir Case Goes Against Teva’s Gamble
November 24, 2009
Novartis has won a patent dispute in a district court with Teva Pharmaceutical Industries over the antiviral drug Famvir, which could make Teva liable for damages due to its short-lived at-risk 2007 launch of a generic version.